Delivery Order SPE2DB20D2014-SPE2DB25FB57P

Award Date 4/8/25
Potential Completion Date 4/9/25
Potential Value $15K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, a Delivery Order valued at $4,423.95, is for the supply of VRAYLAR 3 MG CAPSULE 30S, a specialty medication. The contract has an ultimate completion date of May 14, 2024 and is a Firm Fixed Price agreement. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by...
This federal contract award, valued at $19,952.69, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of VRAYLAR 1.5 MG CAPSULE 30S, a pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of February 1, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order worth $12,955.49 with a Firm Fixed Price pricing type and an ultimate completion date of March 4, 2024. The contract is for the supply of VRAYLAR 1.5 MG CAPSULE 30S, a pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,170.37 firm-fixed-price delivery order is for the supply of VRAYLAR 3 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of October 13, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,967.25 Firm Fixed Price delivery order contract is for the supply of VRAYLAR 3 MG CAPSULE 30S, a pharmaceutical product. The contract has a completion date of June 10, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,644.85 firm-fixed-price delivery order is for the supply of VRAYLAR 3 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of May 30, 2024 and was awarded on May 29, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,396.77 firm fixed-price delivery order is for the supply of VRAYLAR 1.5 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of March 17, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award, valued at $14,734.16, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VRAYLAR 3 MG CAPSULE 30S, a prescription medication. The contract is a Firm Fixed Price Delivery Order with a completion date of December 12, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, a Delivery Order valued at $1,402.84, is for the supply of VRAYLAR 3 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of November 4, 2024 and is a Firm Fixed Price contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,045.38, is a delivery order for the supply of VRAYLAR 1.5 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of April 14, 2025 and is a firm fixed-price arrangement. This contract award is part of a larger Indefinite Delivery Contract (IDC) that...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB25FB57P
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,649.45, is a Delivery Order for the supply of VRAYLAR 3 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of April 9, 2025 and is a Firm Fixed Price contract. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 7/8/25, 2:18 PM